About   Help   FAQ
Gene Ontology Classifications
Symbol
Name
ID
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
MGI:103290

Go Annotations as Summary Text (Tabular View) (GO Graph)

GO curators for mouse genes have assigned the following annotations to the gene product of Rela. (This text reflects annotations as of Thursday, July 24, 2014.)
Summary from NCBI RefSeq


[Summary is not available for the mouse gene. This summary is for the human ortholog.] NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Summary text based on GO annotations supported by experimental evidence in mouse
Summary text based on GO annotations supported by experimental evidence in other organisms
Summary text based on GO annotations supported by structural data
Summary text for additional MGI annotations
References
  1. Ahn E et al. (2006) LIME acts as a transmembrane adapter mediating BCR-dependent B-cell activation. Blood, 107:1521-7. (PubMed:16249387)
  2. Basak S et al. (2007) A fourth IkappaB protein within the NF-kappaB signaling module. Cell, 128:369-81. (PubMed:17254973)
  3. Beg AA et al. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature, 376:167-70. (PubMed:7603567)
  4. Chang M et al. (2011) The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity. Nat Immunol, 12:1002-9. (PubMed:21874024)
  5. Devries IL et al. (2010) Consequences of IkappaB alpha hydroxylation by the factor inhibiting HIF (FIH). FEBS Lett, 584:4725-30. (PubMed:21056038)
  6. Doi TS et al. (1997) NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med, 185:953-61. (PubMed:9120401)
  7. Esteban V et al. (2009) Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS ONE, 4:e5406. (PubMed:19404405)
  8. Fiorini E et al. (2002) Peptide-induced negative selection of thymocytes activates transcription of an NF-kappaB inhibitor. Mol Cell, 9:637-48. (PubMed:11931770)
  9. Fukushima H et al. (2008) The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis. Mol Cell Biol, 28:6402-12. (PubMed:18710934)
  10. Girardin SE et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem, 278:8869-72. (PubMed:12527755)
  11. Herron BJ et al. (2005) A mutation in NFkB interacting protein 1 results in cardiomyopathy and abnormal skin development in wa3 mice. Hum Mol Genet, 14:667-77. (PubMed:15661756)
  12. Hertlein E et al. (2005) RelA/p65 regulation of IkappaBbeta. Mol Cell Biol, 25:4956-68. (PubMed:15923614)
  13. Hoshino K et al. (1999) Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol, 162:5041-4. (PubMed:10227969)
  14. Kim RH et al. (2001) SNIP1 inhibits NF-kappa B signaling by competing for its binding to the C/H1 domain of CBP/p300 transcriptional co-activators. J Biol Chem, 276:46297-304. (PubMed:11567019)
  15. La Rosa FA et al. (1994) Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. Mol Cell Biol, 14:1039-44. (PubMed:8289784)
  16. Levy D et al. (2011) Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat Immunol, 12:29-36. (PubMed:21131967)
  17. Li H et al. (2012) Regulation of NF-kappaB activity by competition between RelA acetylation and ubiquitination. Oncogene, 31:611-23. (PubMed:21706061)
  18. Liu J et al. (2003) Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J Exp Med, 198:1265-76. (PubMed:14568984)
  19. Liu L et al. (2004) Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling. Biochem J, 380:31-41. (PubMed:14961764)
  20. Makowski L et al. (2005) The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem, 280:12888-95. (PubMed:15684432)
  21. Malek S et al. (2003) X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex. J Biol Chem, 278:23094-100. (PubMed:12686541)
  22. Mathes E et al. (2008) NF-kappaB dictates the degradation pathway of IkappaBalpha. EMBO J, 27:1357-67. (PubMed:18401342)
  23. Minoda Y et al. (2006) A novel Zinc finger protein, ZCCHC11, interacts with TIFA and modulates TLR signaling. Biochem Biophys Res Commun, 344:1023-30. (PubMed:16643855)
  24. Mitola S et al. (2008) Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm. Blood, 112:1154-7. (PubMed:18505784)
  25. Mulero MC et al. (2013) Chromatin-bound IkappaBalpha regulates a subset of polycomb target genes in differentiation and cancer. Cancer Cell, 24:151-66. (PubMed:23850221)
  26. Na SY et al. (1998) Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations. J Biol Chem, 273:10831-4. (PubMed:9556555)
  27. O'Connell RM et al. (2005) Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1. J Immunol, 174:1602-7. (PubMed:15661922)
  28. Ossendorp F et al. (2005) Differential expression regulation of the alpha and beta subunits of the PA28 proteasome activator in mature dendritic cells. J Immunol, 174:7815-22. (PubMed:15944286)
  29. Papin J et al. (2004) Bioinformatics and cellular signaling. Curr Opin Biotechnol, 15:78-81. (PubMed:15102471)
  30. Rupec RA et al. (2005) Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity, 22:479-91. (PubMed:15845452)
  31. Saijo K et al. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell, 137:47-59. (PubMed:19345186)
  32. Sawada A et al. (2005) Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor. Development, 132:4719-29. (PubMed:16207754)
  33. Schmidt-Ullrich R et al. (2006) NF-{kappa}B transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth. Development, 133:1045-57. (PubMed:16481354)
  34. Schwitalla S et al. (2013) Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell, 152:25-38. (PubMed:23273993)
  35. Sen N et al. (2012) Hydrogen Sulfide-Linked Sulfhydration of NF-kappaB Mediates Its Antiapoptotic Actions. Mol Cell, 45:13-24. (PubMed:22244329)
  36. Sharif-Askari E et al. (2010) Zinc finger protein Gfi1 controls the endotoxin-mediated Toll-like receptor inflammatory response by antagonizing NF-kappaB p65. Mol Cell Biol, 30:3929-42. (PubMed:20547752)
  37. Shih VF et al. (2012) Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-kappaB pathways. Nat Immunol, 13:1162-70. (PubMed:23086447)
  38. Shim JH et al. (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev, 19:2668-81. (PubMed:16260493)
  39. Song H et al. (2012) Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice. EMBO J, 31:1147-59. (PubMed:22227519)
  40. Spengler ML et al. (2012) Core circadian protein CLOCK is a positive regulator of NF-kappaB-mediated transcription. Proc Natl Acad Sci U S A, 109:E2457-65. (PubMed:22895791)
  41. Watanabe T et al. (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol, 5:800-8. (PubMed:15220916)
  42. Wilmanski J et al. (2005) Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages. J Leukoc Biol, 78:85-94. (PubMed:15817708)
  43. Yuk JM et al. (2011) The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nat Immunol, 12:742-51. (PubMed:21725320)
  44. Zhang J et al. (2013) A newly identified microRNA, mmu-miR-7578, functions as a negative regulator on inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 via targeting Egr1 in vivo. J Biol Chem, 288:4310-20. (PubMed:23184950)
  45. Zhang Y et al. (2009) Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction. Dev Cell, 17:49-61. (PubMed:19619491)
  46. Zhong H et al. (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell, 9:625-36. (PubMed:11931769)



Go Annotations in Tabular Form (Text View) (GO Graph)

 
 


Gene Ontology Evidence Code Abbreviations:

  EXP Inferred from experiment
  IC Inferred by curator
  IDA Inferred from direct assay
  IEA Inferred from electronic annotation
  IGI Inferred from genetic interaction
  IMP Inferred from mutant phenotype
  IPI Inferred from physical interaction
  ISS Inferred from sequence or structural similarity
  ISO Inferred from sequence orthology
  ISA Inferred from sequence alignment
  ISM Inferred from sequence model
  NAS Non-traceable author statement
  ND No biological data available
  RCA Reviewed computational analysis
  TAS Traceable author statement


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
09/09/2014
MGI 5.19
The Jackson Laboratory